moa glp 1 agonist GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes The dual glucose-dependent insulinotropic polypeptide
Description
The Framework provides common policy direction to help align efforts and to support improved access prevention and treatment for all types of diabetes to ensure better health outcomes
(Updated 2022 Nov 14)
Weight loss was paralleled by a statistically significant decrease in BMI at M6 (3.4 kg/m 2 [2.5] vs.1.7 kg/m 2 [2.0]
Therefore, the regulation of the activity of microglia is believed to play a key role in the neuroinflammation of PD
A recent meta-analysis of 18 studies concluded that this effect is significant and warrants further investigation
Clinical practice guideline on pharmacological interventions for adults with obesity
